Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
Abroad (travel likely)RecruitingPHASE1, PHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Glioblastoma Multiforme
Locations
- University of Southern California, Los Angeles, California, United States
- Saint John Cancer Institute, Santa Monica, California, United States
- Georgia Cancer Center (Augusta University), Augusta, Georgia, United States
- Ochsner Health, New Orleans, Louisiana, United States
- Atlantic Health (Overlook Medical Center), Summit, New Jersey, United States
- Northwell Health, New York, New York, United States
- Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- Baylor Scott & White Health, Dallas, Texas, United States
- University of Texas Southwestern Medical Center, Dallas, Texas, United States
- University of Washington Medical Center, Seattle, Washington, United States
- University of Wisconsin Hospital and Clinic, Madison, Wisconsin, United States